* Healthequity Inc HQY.OQ HQY.O is expected to show a
rise in
quarterly revenue when it reports results on March 19 for the
period ending January 31 2024
* The Draper Utah-based company is expected to report a
10.5% increase in revenue to $258.466 million from $233.84
million a year ago, according to the mean estimate from 11
analysts, based on LSEG data. (SAL majority is based on Total
Revenue)
* LSEG's mean analyst estimate for Healthequity Inc is for
earnings of 56 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for
Healthequity Inc
is $95.00, above its last closing price of $82.02.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Oct. 31 2023 0.50 0.50 0.60 Beat 20
Jul. 31 2023 0.48 0.48 0.53 Beat 11
Apr. 30 2023 0.41 0.41 0.50 Beat 23.2
Jan. 31 2023 0.35 0.35 0.37 Beat 5.4
Oct. 0.35 0.35 0.38 Beat 9.7
31 2022
Jul. 31 2022 0.33 0.33 0.33 Met 0
Apr. 30 2022 0.25 0.26 0.27 Beat 3.8
Jan. 31 2022 0.21 0.22 0.20 Missed -7.8
This summary was machine generated March 15 at 21:13 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)